A Phase 1/2 Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
Condition: Whooping Cough Interventions: Biological: Vaccine GamLPV; Other: Placebo Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cough | Epidemiology | Microbiology | Research | Russia Health | Study | Vaccines | Whooping Cough | Whooping Cough (Pertussis) Vaccine